Geistlich specializes in the regeneration of bone, cartilage and tissue. The company's regenerative medical devices aim to improve patients’ quality of life.

Geistlich Pharma AG

Amazon

Font Awesome

IPv6

jsDelivr

HSTS IncludeSubdomains PreLoad

Amazon S3

Ruby on Rails Token

Google Conversion Linker

Google Remarketing

Gudrun Denke

Deputy Director Preclinical and Clinical Research & Development

Urs Iten

CIO / Director Group IT

New Jersey Companies With Fewer Than 1000 Employees (Top 10K)

New Jersey Medical Companies

United States Companies With More Than 500 Employees (Top 10K)

East Coast Companies With More Than 100 Employees (Top 10K)

Geistlich Pharma North America brings the leader in regenerative dentistry directly to the United States and Canada. For 160 years, their respected family-owned Swiss parent company has pioneered technological advances that make regenerative treatment, with safe and naturally sourced biomaterials, the preferred choice for clinical predictability.

Princeton

New Jersey

United States

North America

Geistlich Pharma

Dental Membrane and Bone Graft Substitute Market to Hit USD 2.2 Billion by 2032, at a CAGR 7.1% | VMR

Geistlich Pharma on LinkedIn: Strategic investment in France

New Work Showcase: Quaint x Geistlich Pharma

Geistlich Pharma India Pvt. Ltd. on LinkedIn: #geistlich #regenerationexpert #givesmilesolidfoundation

Dental Bone Graft Materials Market Analyzing Size, Share ...

Bone Grafts & Substitutes Market worth $5.24 billion by 2030, growing at a CAGR of 6.60% - Exclusive Report by

Bone grafts and substitutes market size to grow by USD ...

Active Implants Enters Partnership with Geistlich Pharma AG for NUsurface® Meniscus Prosthesis

Geistlich Pharma Granted FDA Breakthrough Device Designation for Chondro-Gide® Articular Cartilage Cover

Italy

Europe

Switzerland

Chile

South America

Hungary

HTML5

Wistia

Apache Server

Adobe Fonts

Vimeo

Google Fonts

Google Maps API

Google Drive

Google Analytics

Bootstrap

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 27, 2024 4:56 PM	2014ecf7
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 27, 2024 4:56 PM	ca283398
crunchbase trigger	general	Nov 12, 2024 12:52 PM	641e1ff7
crunchbase profile	general	Nov 12, 2024 8:48 PM	7a619fa9
li profile	general
translate crunchbase fundingrounds	general	Nov 12, 2024 9:22 PM	6b670514
peers	general	Sep 27, 2024 4:56 PM	8a00b714
news basic	general	Sep 27, 2024 4:56 PM	6ea157f7
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:GEISTLICH

Geistlich Pharma AG